Serina Therapeutics's total assets for Q3 2025 were $12.41M, an increase of 38.83% from the previous quarter. SER total liabilities were $10.82M for the fiscal quarter, a 48.31% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.